Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

S&P 500 Rises 1%; US Wholesale Inventories Fall In August

Author: Lisa Levin | October 10, 2023 12:04pm

U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 250 points on Tuesday.

The Dow traded up 0.81% to 33,876.62 while the NASDAQ rose 1.23% to 13,650.54. The S&P 500 also rose, gaining, 1.10% to 4,383.17.

Check This Out: Walgreens Likely To Report Lower Q4 Earnings; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts

 

Leading and Lagging Sectors

 

Consumer discretionary shares rose by 1.4% on Tuesday.

In trading on Tuesday, energy shares fell by around 0.1%.

 

Top Headline

 

U.S. wholesale inventories fell 0.1% month-over-month in August.

 

Equities Trading UP

 

SMX (Security Matters) Public Limited Company (NASDAQ:SMX) shares shot up 99% to $3.3841 after the company announced it secured a majority stake in True Gold Consortium.

Shares of Intrusion Inc. (NASDAQ:INTZ) got a boost, shooting 46% to $0.5094. Intrusion has been awarded a $5 million agreement with a large telecommunications provider to provide Intrusion Shield support for its data centers.

Startek, Inc. (NYSE:SRT) shares were also up, gaining 29% to $4.2191 as the company agreed to be acquired by funds managed by CSP Management Limited for $4.30 per share in cash.

 

Equities Trading DOWN

 

Akero Therapeutics, Inc. (NASDAQ:AKRO) shares dropped 66% to $16.72 after the company reported a 36-week analysis of its Phase 2b SYMMETRY study evaluating the efficacy and safety of its lead product candidate efruxifermin.

Shares of Athersys, Inc. (NASDAQ:ATHX) were down 47% to $0.16 after the company reported interim analysis results of MASTERS-2 clinical study with multistem in ischemic stroke and signed a Memorandum of Understanding for global ARDS license with Healios.

Ventyx Biosciences, Inc. (NASDAQ:VTYX) was down, falling 24% to $22.95 after the company announced results from the Phase 2 trial of VTX002 in patients with moderate-to-severely active ulcerative colitis.

Also Check This Out: Check Out 3 High-Yielding Dividend Stocks In Energy Sector From Wall Street's Most Accurate Analysts

 

Commodities

 

In commodity news, oil traded down 1% to $85.53 while gold traded up 0.3% at $1,869.50.

Silver traded up 0.2% to $21.96 on Tuesday while copper fell 0.9% to $3.6145.

 

Euro zone

 

European shares were higher today. The eurozone’s STOXX 600 gained 1.8% London’s FTSE 100 gained 1.74% while Spain’s IBEX 35 Index rose 2.3% The German DAX rose 1.86% French CAC 40 climbed 1.84%, while Italy’s FTSE MIB Index gained 2.3%.

Industrial production in Italy rose 0.2% month-over-month in August following a revised 0.9% fall in July. Retail sales in the UK rose 2.8% from a year ago in September.

 

Asia Pacific Markets

 

Asian markets closed mostly higher on Tuesday, with Japan’s Nikkei 225 gaining 2.43%, China’s Shanghai Composite Index falling 0.70% and Hong Kong’s Hang Seng Index gaining 0.84%. India’s S&P BSE Sensex, meanwhile, rose 0.9%.

Japan's current account surplus narrowed to JPY 2.280 trillion in August from JPY 2.772 trillion in the prior month, compared to market estimates of JPY 3.091 trillion.

 

Economics

 

The NFIB Small Business Optimism Index fell for a second month to a reading of 90.8 in September from 91.3 in the prior month.

U.S. wholesale inventories fell 0.1% month-over-month in August.

Now Read This: Top 3 Tech And Telecom Stocks You May Want To Dump In October

Posted In: AKRO ATHX INTZ SMX SRT VTYX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist